Treatments and Targets to Achieve Disease Control in Chronic Spontaneous Urticaria: Current and Emerging Therapeutic Options.

J Inflamm Res · 2026 · PMC12968031 · PMID 41809769

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although improvements in UAS7 and ISS7 were also observed in omalizumab non-responders or intolerant patients, the effect was attenuated and did not reach statistical significance for ISS7 at week 24.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.